إعلان
إعلان
ABUS
Arbutus Biopharma Corporation Common Stock
4.62
USDبرعاية
-0.04
-0.75%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
4.69
+0.07
+1.60%
تقارير أرباح ABUS
النسبة الإيجابية المفاجئة
ABUS تفوق 22 من 40 آخر التقديرات.
55%
التقرير التالي
بيانات التقرير القادم
٢٥ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$714.00K
/-$0.03
التغير الضمني من Q3 25 (Revenue/ EPS)
+34.97%
/-25.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
-54.64%
/-57.14%
Arbutus Biopharma Corporation Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, ABUS reported earnings of -0.04 USD per share (EPS) for Q3 25, missing the estimate of -0.03 USD, resulting in a -26.58% surprise. Revenue reached 529.00 ألف, compared to an expected 1.29 مليون, with a -59.06% difference. The market reacted with a -5.79% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -0.03 USD, with revenue projected to reach 714.00 ألف USD, implying an نقصان of -25.00% EPS, and زيادة of 34.97% in Revenue from the last quarter.
الأسئلة الشائعة
What were Arbutus Biopharma Corporation Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Arbutus Biopharma Corporation Common Stock reported EPS of -$0.04, missing estimates by -26.58%, and revenue of $529.00K, -59.06% below expectations.
How did the market react to Arbutus Biopharma Corporation Common Stock's Q3 2025 earnings?
The stock price moved down -5.79%, changed from $4.84 before the earnings release to $4.56 the day after.
When is Arbutus Biopharma Corporation Common Stock expected to report next?
The next earning report is scheduled for ٢٥ مارس ٢٠٢٦.
What are the forecasts for Arbutus Biopharma Corporation Common Stock's next earnings report?
Based on 5
المحللين, Arbutus Biopharma Corporation Common Stock is expected to report EPS of -$0.03 and revenue of $714.00K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان